452 related articles for article (PubMed ID: 22836056)
41. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation.
Widesott L; Pierelli A; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Di Muzio N; Fazio F; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):589-96. PubMed ID: 18793962
[TBL] [Abstract][Full Text] [Related]
42. A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials.
Roesink JM; Schipper M; Busschers W; Raaijmakers CP; Terhaard CH
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1006-9. PubMed ID: 15964708
[TBL] [Abstract][Full Text] [Related]
43. Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site.
Bhide S; Clark C; Harrington K; Nutting CM
Med Dosim; 2007; 32(3):188-95. PubMed ID: 17707198
[TBL] [Abstract][Full Text] [Related]
44. A study on the impact of patient-related parameters in the ability to spare parotid glands by intensity-modulated radiotherapy for head and neck squamous cell carcinomas.
Bandlamudi BP; Sharan K; Yathiraj PH; Singh A; Reddy A; Fernandes DJ; Srinivasa VM
J Cancer Res Ther; 2018; 14(6):1220-1224. PubMed ID: 30488833
[TBL] [Abstract][Full Text] [Related]
45. Effect of regression of enlarged neck lymph nodes on radiation doses received by parotid glands during intensity-modulated radiotherapy for head and neck cancer.
Kuo YC; Wu TH; Chung TS; Huang KW; Chao KS; Su WC; Chiou JF
Am J Clin Oncol; 2006 Dec; 29(6):600-5. PubMed ID: 17148998
[TBL] [Abstract][Full Text] [Related]
46. Impact of Node Negative Target Volume Delineation on Contralateral Parotid Gland Dose Sparing Using IMRT in Head and Neck Cancer.
Magnuson WJ; Urban E; Bayliss RA; Harari PM
Technol Cancer Res Treat; 2015 Jun; 14(3):315-9. PubMed ID: 25782188
[TBL] [Abstract][Full Text] [Related]
47. Helical tomotherapy for head and neck squamous cell carcinoma: dosimetric comparison with linear accelerator-based step-and-shoot IMRT.
Murthy V; Master Z; Gupta T; Ghosh-Laskar S; Budrukkar A; Phurailatpam R; Agarwal J
J Cancer Res Ther; 2010; 6(2):194-8. PubMed ID: 20622367
[TBL] [Abstract][Full Text] [Related]
48. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome.
Bi XW; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Ren H; Dai JR
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1086-93. PubMed ID: 24120822
[TBL] [Abstract][Full Text] [Related]
49. Patterns-of-failure after helical tomotherapy-based chemoradiotherapy for head and neck cancer: implications for CTV margin, elective nodal dose and bilateral parotid sparing.
Dandekar V; Morgan T; Turian J; Fidler MJ; Showel J; Nielsen T; Coleman J; Diaz A; Sher DJ
Oral Oncol; 2014 May; 50(5):520-6. PubMed ID: 24613544
[TBL] [Abstract][Full Text] [Related]
50. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
[TBL] [Abstract][Full Text] [Related]
51. Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration.
Lee C; Langen KM; Lu W; Haimerl J; Schnarr E; Ruchala KJ; Olivera GH; Meeks SL; Kupelian PA; Shellenberger TD; Mañon RR
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1563-71. PubMed ID: 18538505
[TBL] [Abstract][Full Text] [Related]
52. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
[TBL] [Abstract][Full Text] [Related]
53. The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy.
Li Y; Taylor JM; Ten Haken RK; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):660-9. PubMed ID: 17141973
[TBL] [Abstract][Full Text] [Related]
54. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
[TBL] [Abstract][Full Text] [Related]
55. A Study to Assess the Dosimetric Impact of the Anatomical Changes Occurring in the Parotid Glands and Tumour Volume during Intensity Modulated Radiotherapy using Simultaneous Integrated Boost (IMRT-SIB) in Head and Neck Squamous Cell Cancers.
Ghosh A; Gupta S; Johny D; Vidyadhar Bhosale V; Pal Singh Negi M
Cancer Med; 2021 Aug; 10(15):5175-5190. PubMed ID: 34159749
[TBL] [Abstract][Full Text] [Related]
56. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
[TBL] [Abstract][Full Text] [Related]
57. Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines.
Guerrero Urbano MT; Clark CH; Kong C; Miles E; Dearnaley DP; Harrington KJ; Nutting CM; PARSPORT Trial Management Group
Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):604-13. PubMed ID: 17706404
[TBL] [Abstract][Full Text] [Related]
58. The Shape of Parotid DVH Predicts the Entity of Gland Deformation During IMRT for Head and Neck Cancers.
Broggi S; Scalco E; Fiorino C; Belli ML; Sanguineti G; Ricchetti F; Dell'Oca I; Dinapoli N; Valentini V; Di Muzio N; Cattaneo GM; Rizzo G
Technol Cancer Res Treat; 2015 Dec; 14(6):683-91. PubMed ID: 24945374
[TBL] [Abstract][Full Text] [Related]
59. Investigations on parotid gland recovery after IMRT in head and neck tumor patients.
Stock M; Dörr W; Stromberger C; Mock U; Koizar S; Pötter R; Georg D
Strahlenther Onkol; 2010 Dec; 186(12):665-71. PubMed ID: 21136030
[TBL] [Abstract][Full Text] [Related]
60. Density variation of parotid glands during IMRT for head-neck cancer: correlation with treatment and anatomical parameters.
Fiorino C; Rizzo G; Scalco E; Broggi S; Belli ML; Dell'Oca I; Dinapoli N; Ricchetti F; Rodriguez AM; Di Muzio N; Calandrino R; Sanguineti G; Valentini V; Cattaneo GM
Radiother Oncol; 2012 Aug; 104(2):224-9. PubMed ID: 22809587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
